Literature DB >> 20102115

The place of interstitial brachytherapy and radiosurgery for low-grade gliomas.

F W Kreth1, N Thon, A Siefert, J C Tonn.   

Abstract

Even though stereotactic brachytherapy has been used for treatment of complex located low-grade glioma for many years, its place within modern treatment concepts is still debated and only a few centers have gained experience with this complex treatment modality. The current article reviews selection criteria, treatment protocols, radiobiology, treatment effects, risk models and side effects of stereotactic brachytherapy. Potentially alternative techniques such as radiosurgery were also reviewed under consideration of radiobiological similarities and differences.

Entities:  

Mesh：

Year:  2010        PMID： 20102115     DOI： 10.1007/978-3-211-99481-8_7

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN： 0095-4829


  13 in total

Review 1.  The role of surgery in grade II/III oligodendroglial tumors.

Authors:  Niklas Thon; Friedrich-Wilhelm Kreth; Joerg-Christian Tonn
Journal:  CNS Oncol       Date:  2015-10-19

2.  Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.

Authors:  Philipp Kickingereder; Christina Hamisch; Bogdana Suchorska; Norbert Galldiks; Veerle Visser-Vandewalle; Roland Goldbrunner; Martin Kocher; Harald Treuer; Juergen Voges; Maximilian I Ruge
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

Review 3.  [Computer-controlled high-precision radiation].

Authors:  D Rueß; M Kocher; H Treuer; M I Ruge
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

4.  Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.

Authors:  Pilar de la Puente; Nicole Fettig; Micah J Luderer; Abbey Jin; Shruti Shah; Barbara Muz; Vaishali Kapoor; Sreekrishna M Goddu; Noha Nabil Salama; Christina Tsien; Dinesh Thotala; Kooresh Shoghi; Buck Rogers; Abdel Kareem Azab
Journal:  J Pharm Sci       Date:  2017-11-21       Impact factor: 3.534

5.  Incidence of vasculopathy in children with hypothalamic/chiasmatic gliomas treated with brachytherapy.

Authors:  U Tacke; D Karger; J Spreer; A Berlis; G Nikkhah; R Korinthenberg
Journal:  Childs Nerv Syst       Date:  2011-03-17       Impact factor: 1.475

Review 6.  [Local therapy of primary brain tumors].

Authors:  M Westphal; W Stummer
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

7.  Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.

Authors:  Maximilian I Ruge; Philipp Kickingereder; Stefan Grau; Franziska Dorn; Norbert Galldiks; Harald Treuer; Volker Sturm
Journal:  Neuro Oncol       Date:  2013-09-17       Impact factor: 12.300

8.  Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome.

Authors:  Maximilian I Ruge; Philipp Kickingereder; Thorsten Simon; Harald Treuer; Volker Sturm
Journal:  J Neurooncol       Date:  2012-05-12       Impact factor: 4.130

Review 9.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

10.  Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.

Authors:  Defeng Zhao; Liren Qian; Jianliang Shen; Xiaopeng Liu; Ke Mei; Jian Cen; Yaming Wang; Congyong Li; Yuanyuan Ma
Journal:  J Cell Mol Med       Date:  2014-03-13       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.